The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
AlphaBiomics awarded ISO 13485 accreditation.
Read more here.
The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
Winner of the 2018 European Innovation Quickfire Challenge (read more)